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In the second study specimens were similarly collected from 180 women attendirLg a sexually transmitted diseases (STD) clinic.
Eighteen cultures were positive for C trachomatis and 4/18 (22%) were positive in the urethral specimen alone.2 Though the percentage of patients yielding positive specimens from the urethra alone was high, the absolute number was small. It is therefore uneconomical to collect routinely separate cervical and urethral specimens for chlamydial culture.
The following protocol was devised in an attempt to contain costs while not missing patients who were harbouring chlamydiae in the urethra but not in the cervix. Using a cotton wool wire shafted swab, a specimen is first collected from the cleansed urethra and placed into a bottle of chlamydia transport medium (CTM). The cervix is then visualised and cleansed, and a further swab from the endocervix is placed in Minocycline 50 mg twice daily for seven days has been shown to be as effective as longer regimens and higher doses of this tetracycline for treating urethral infection with C trachomatis in men.4' No similar study of the use of minocycline for treating genital chlamydial infection in women has been reported, and this antimicrobial is not listed in a recent summary of treatment regimens in women. 6 We have recently evaluated minocycline 50 mg twice daily for seven days in the treatment of genital infection by C trachomatis in women.
From February to October 1983 we performed cervical culture for C trachomatis, using cycloheximide treated McCoy cells, on 603 patients; those who had taken antimicrobials during the preceding four weeks were excluded, but patients were otherwise unselected. C trachomatis was isolated from 222 women. Of these, 79 were contacs of men with non-gonococcal urethritis and the remainder had yielded C trachomatis after We would like to see formal requirements for training in this skill recognised by our Specialist Advisory Committee for accreditation.
The provision of resources to continue developing colposcopy services in our speciality should be given a clear priority so that "routine" genitourinary patients are not denied access to clinics where colposcopy is performed. Where better to begin the investigation and treatment of abnormal cytology than in the clinics to which "at risk" patients present themselves and where such cytology is disproportionately to be found?
As the relations between wart virus subtypes, other possible infections, and noninfectious cofactors, and the progression of dysplasia are far from clear, where better to investigate these than in departments of genitourinary medicine? Moreover, the colposcope's potential in visualising nondysplastic conditions and lesions at other sites is only beginning to be developed.
A harmonious relationship seems to be present between individual experienced genitourinary physicians and gynaecological colleagues, which is reflected in the common interest in the instrument and patient sharing. We understand that this co-operation is evident in more formal terms, as the BSCCP has approached the MSSVD to further detailed discussions and develop training courses designed for genitourinary staff.
We would value the comments of our colleagues. 
